In a decisive move to enhance its chronic pain management solutions, US-based medical technology firm Avanos Medical has announced plans to acquire Diros Technology, a manufacturer of innovative radiofrequency (RF) products used in chronic pain treatment. The financial terms of the deal were not revealed. The Toronto-based Diros Technology is a pioneering company in radiofrequency […]
Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate for Solution for Injection under the brand name REMITHEM. The drug has been authorized to be used as an analgesic medication for the induction and maintenance of general anesthesia during […]
Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials from the US Food and Drug Administration (FDA). The product is the generic version of Roche’s Toradol Injection, 15 mg/mL, 30 mg/mL, and 60 […]
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (FDA) for Ibuprofen Oral Suspension USP, 50 mg/1.25 mL (40 mg/mL) (OTC). The pain drug product from Strides Pharma is the generic of GlaxoSmithKline Consumer Healthcare Holdings (US)’s […]
Dr. Reddy’s Laboratories and its partner Senores Pharmaceuticals have launched Ketorolac Tromethamine Tablets USP, 10 mg, in the US market. The launched product is a generic equivalent of Toradol Tablets, 10 mg, which has the approval of the US Food and Drug Administration (FDA) for the short-term treatment of moderate to severe pain in adults. […]
Hempsana Holdings said that it has forged a custom manufacturing deal with Cream of the Crop Therapeutics to launch the latter’s Terpene Rich formulated product. As per the agreement terms, the Canada-based Hempsana will exclusively manufacture Cream of the Crop Therapeutics’ Terpene Rich Relief Cream. The cannabinoid derivatives manufacturer will be responsible for supplying cannabis […]
Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative for reducing the use of conventional opioids in patients with acute pain. Avenue Therapeutics had been issued a second complete response letter (CRL) pertaining to its new drug application (NDA) […]
Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 for its use in reducing osteoarthritis (OA) pain. The mid-stage clinical study will assess the effectiveness of ATB-346 in the reduction of OA knee pain in comparison to placebo in […]
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin is an enteric-coated tablet which does not upset the stomach. Aspirin tablets are mainly used to lower the stroke risk in persons who had a mini-stroke (transient ischemic attack) or […]
Pennsylvania-based Alliqua BioMedical has announced a significant merger with San Francisco’s Adynxx, aiming to establish a clinical-stage pharmaceutical entity dedicated to non-opioid pain management therapies. This strategic move promises to revolutionize pain treatment by developing disease-modifying solutions. Under the terms of the merger, Adynxx stockholders will emerge as the primary owners of Alliqua’s outstanding common […]